1
|
Cohen E, Lheure C, Ingen-Housz-Oro S, Hotz C, Bettuzzi T, Chasset F, Descamps V, Deschamps L, Mahevas M, Terrier B, Sohier P, Guegan S, Kramkimel N, Darbord D, Chanal J, Oulès B, Aractingi S, Seta V, Dupin N. Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients. Eur J Dermatol 2023; 33:680-685. [PMID: 38465550 DOI: 10.1684/ejd.2023.4584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/12/2024]
Abstract
Sarcoidosis is a systemic disease that affects the skin in about 25% of patients. The treatment of cutaneous sarcoidosis is guided by the extent of lesions, associated symptoms and organ involvement. To evaluate rates of response to various potential first-line treatments for cutaneous sarcoidosis during the year following treatment initiation. This retrospective multicentre study included 120 patients with cutaneous sarcoidosis. Treatment response was assessed retrospectively from the patients' medical records. Univariate logistic regression analysis, with an estimation of unadjusted odds ratios (OR) and their 95% CI ,was performed to identify factors associated with complete cutaneous remission (CR), followed by multivariate logistic regression analysis. At one year, 43 of the 120 (36%) included patients had CR. The best response rates were obtained with oral corticosteroids (12/21, 57%), followed by a combination of hydroxychloroquine and topical steroids (6/13, 46%). In multivariate analysis, lupus pernio was the only predictor of a poor cutaneous response. We suggest the use of a combination of hydroxychloroquine and topical steroids as an optimal first-line treatment for cutaneous sarcoidosis, given the known adverse effects of systemic corticosteroids.
Collapse
Affiliation(s)
- Elisabeth Cohen
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Coralie Lheure
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Saskia Ingen-Housz-Oro
- Department of Dermatology, APHP, Mondor Hospital, Paris, France, EpiDermE, University Paris Est Créteil, Créteil, France
| | - Claire Hotz
- Department of Dermatology, APHP, Mondor Hospital, Paris, France
| | - Thomas Bettuzzi
- Department of Dermatology, APHP, Mondor Hospital, Paris, France
| | | | | | - Lydia Deschamps
- Department of Pathology, APHP, Bichat Hospital, Paris, France
| | - Matthieu Mahevas
- Department of Internal Medicine, APHP, Mondor Hospital, Paris, France
| | - Benjamin Terrier
- Department of Internal Medicine, APHP, Cochin Hospital, Paris, France
| | - Pierre Sohier
- Department of Pathology, APHP, Cochin Hospital, Paris, France
| | - Sarah Guegan
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Nora Kramkimel
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | | | - Johan Chanal
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Benedicte Oulès
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Selim Aractingi
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Vannina Seta
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| | - Nicolas Dupin
- Department of Dermatology, APHP, Cochin Hospital, Paris, France
| |
Collapse
|
2
|
Annabi E, Dupin N, Sohier P, Garel B, Franck N, Aractingi S, Guégan S, Oulès B. Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature. J Eur Acad Dermatol Venereol 2021; 35:e847-e850. [PMID: 34363637 PMCID: PMC8447383 DOI: 10.1111/jdv.17578] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Accepted: 07/30/2021] [Indexed: 01/26/2023]
Affiliation(s)
- E Annabi
- Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP.Centre-Université de Paris, Paris, France
| | - N Dupin
- Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP.Centre-Université de Paris, Paris, France.,Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Cutaneous Biology Lab, Institut Cochin, INSERM, Paris, France
| | - P Sohier
- Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Cutaneous Biology Lab, Institut Cochin, INSERM, Paris, France.,Department of Pathology, Hôpital Cochin, AP-HP, AP-HP.Centre-Université de Paris, Paris, France
| | - B Garel
- Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP.Centre-Université de Paris, Paris, France
| | - N Franck
- Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP.Centre-Université de Paris, Paris, France
| | - S Aractingi
- Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP.Centre-Université de Paris, Paris, France.,Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Cutaneous Biology Lab, Institut Cochin, INSERM, Paris, France
| | - S Guégan
- Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP.Centre-Université de Paris, Paris, France.,Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Cutaneous Biology Lab, Institut Cochin, INSERM, Paris, France
| | - B Oulès
- Department of Dermatology, Hôpital Cochin, AP-HP, AP-HP.Centre-Université de Paris, Paris, France.,Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Cutaneous Biology Lab, Institut Cochin, INSERM, Paris, France
| |
Collapse
|
3
|
Bozonnat A, Garel B, Oulès B, Sohier P, Plantier F, Deau-Fischer B, Franck N, Aractingi S, Dupin N. Efficacité de l’ibrutinib dans le traitement d’un xanthogranulome nécrobiotique associé à une lymphocytose B monoclonale. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
4
|
Dutertre M, Garel B, Tournier A, Oulès B, Franck N, Kramkimel N, Klejtman T, Descamps V, Dupin N, Brunet-Possenti F, Aractingi S, Heure C, Guégan S. Syndrome d’activation macrophagique induit par l’association ipilimumab et nivolumab chez 2 patients atteints de mélanome stade IV. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
5
|
Oulès B, Deschamps L, Frouin E, Battistella M. GATA6 identifie les tumeurs de la partie supérieure du follicule pilo-sébacé. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
6
|
Oulès B, Mourah S, Baroudjian B, Jouenne F, Delyon J, Louveau B, Gruber A, Lebbe C, Battistella M. Les mélanomes mutés CTNNB1 : description clinique, histologique et génétique. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Calmettes V, Lheure C, Oulès B, Franck N, Chanal J, Garel B, Klejtman T, Guégan S, Brunet-Possenti F, Descamps V, Dupin N, Aractingi S, Kramkimel N. Étude en « vie réelle » de la tolérance du traitement adjuvant par anti-PD1 dans le mélanome stade III ou IV de résection complète. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
8
|
Matar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, Aractingi S. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. J Eur Acad Dermatol Venereol 2020; 34:e686-e689. [PMID: 32589293 PMCID: PMC7361331 DOI: 10.1111/jdv.16775] [Citation(s) in RCA: 51] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Accepted: 06/16/2020] [Indexed: 01/08/2023]
Affiliation(s)
- S Matar
- Department of Dermatology, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre Cochin-Hôtel Dieu-Broca, Paris, France
| | - B Oulès
- Department of Dermatology, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre Cochin-Hôtel Dieu-Broca, Paris, France.,Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Cutaneous Biology Lab, INSERM U1016, UMR8104, Institut Cochin, Paris, France
| | - P Sohier
- Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Department of Pathology, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre Cochin-Hôtel Dieu-Broca, Paris, France
| | - O Chosidow
- Department of Dermatology, Hôpital Henri Mondor, AP-HP, Hôpitaux Universitaires Henri Mondor, Créteil, France.,Research Group Dynamyc, EA7380, Faculté de Médecine, Université Paris-Est Créteil, Ecole nationale vétérinaire d'Alfort, USC ANSES, Créteil, France
| | - M Beylot-Barry
- Department of Dermatology, CHU Bordeaux, Bordeaux, France.,Bordeaux Research in Translational Oncology, INSERM U1053, Bordeaux, France
| | - N Dupin
- Department of Dermatology, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre Cochin-Hôtel Dieu-Broca, Paris, France.,Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Cutaneous Biology Lab, INSERM U1016, UMR8104, Institut Cochin, Paris, France
| | - S Aractingi
- Department of Dermatology, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre Cochin-Hôtel Dieu-Broca, Paris, France.,Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.,Cutaneous Biology Lab, INSERM U1016, UMR8104, Institut Cochin, Paris, France
| |
Collapse
|